From owner-cardiors@hgmp.mrc.ac.uk Sat Dec 1 23:42:23 2001 Return-Path: Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 505F717A62 for ; Sat, 1 Dec 2001 23:42:23 +0000 (GMT) Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 423C117A66 for ; Sat, 1 Dec 2001 23:42:21 +0000 (GMT) Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 47DEF17A62 for ; Sat, 1 Dec 2001 23:42:20 +0000 (GMT) Received: (from news@localhost) by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id XAA20824 for cardiors-list@hgmp.mrc.ac.uk; Sat, 1 Dec 2001 23:36:12 GMT X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to using -f From: memebersip@winnerspaid.com X-Newsgroups: bionet.biology.cardiovascular Subject: win a car Date: 1 Dec 2001 23:36:09 -0000 Organization: BIOSCI/MRC Human Genome Mapping Project Resource Centre Lines: 37 Message-ID: <000028c80b4e$00000819$00007b28@194.178.46.100> Mime-Version: 1.0 Content-Type: text/html; charset="iso-8859-1" Content-Transfer-Encoding: quoted-printable X-Complaints-To: news@net.bio.net X-Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 083A117A5E for ; Sat, 1 Dec 2001 23:36:07 +0000 (GMT) X-Received: from drhelp_main.drhelp.co.kr (unknown [211.33.134.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id D451517A66 for ; Sat, 1 Dec 2001 23:36:05 +0000 (GMT) X-Received: from 62.104.1.34 [209.158.14.18] by drhelp_main.drhelp.co.kr (SMTPD32-6.00) id AA4824A007E; Sun, 02 Dec 2001 08:39:52 +0900 X-To: X-Priority: 3 X-MSMail-Priority: Normal To: cardiors@hgmp.mrc.ac.uk Sender: owner-cardiors@hgmp.mrc.ac.uk Precedence: bulk
IS THIS YOUR CAR?


It's a tricked out 1923 T-Bucket Hot Ro= d, with a high performance Chevrolet engine!

This Babe Magnet is being given away, no strings attached, to some lucky s= urfer,
just for looking at free XXX pics and video.

CLICK HERE for a chance = to drive this baby home!


When you click on the link, you'll get hundreds of thousands of FREE porn = pics

and videos with never a charge of any kind. No credit cards, no dialers, = no phone bills!


NO CHARGES OF ANY KIND!!!<= /b>

You also have a chance at other great priz= es like Palm Pilots,
computer monitors, MP3 players, digital cameras a= nd much more!

Did I mention the hundreds of thousands of FREE XXX pics and video?

CLICK HERE NOW for a cha= nce to win great prizes for looking at Free Porn!


--- From owner-cardiors@hgmp.mrc.ac.uk Mon Dec 3 21:57:31 2001 Return-Path: Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 5D45617AF3 for ; Mon, 3 Dec 2001 21:57:30 +0000 (GMT) Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 4C18817AFC for ; Mon, 3 Dec 2001 21:57:25 +0000 (GMT) Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id CBB2217AF3 for ; Mon, 3 Dec 2001 21:57:23 +0000 (GMT) Received: (from news@localhost) by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id VAA20316 for cardiors-list@hgmp.mrc.ac.uk; Mon, 3 Dec 2001 21:52:18 GMT X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to using -f From: Ma Hongbao X-Newsgroups: bionet.biology.cardiovascular Subject: Living is a right Date: Mon, 03 Dec 2001 16:46:49 -0500 Organization: Michigan State University Lines: 2 Message-ID: <3C0BF2C9.90402@netscape.net> Mime-Version: 1.0 Content-Type: text/plain; charset=us-ascii; format=flowed Content-Transfer-Encoding: 7bit User-Agent: Mozilla/5.0 (Windows; U; Win 9x 4.90; en-US; rv:0.9.4) Gecko/20011019 Netscape6/6.2 X-Accept-Language: en-us To: cardiors@hgmp.mrc.ac.uk Sender: owner-cardiors@hgmp.mrc.ac.uk Precedence: bulk All humans have the same right to live in the world. From owner-cardiors@hgmp.mrc.ac.uk Tue Dec 4 01:57:32 2001 Return-Path: Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 13A7F17AA5 for ; Tue, 4 Dec 2001 01:57:31 +0000 (GMT) Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id A69EC17AF8 for ; Tue, 4 Dec 2001 01:57:26 +0000 (GMT) Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 51A2017A8C for ; Tue, 4 Dec 2001 01:57:24 +0000 (GMT) Received: (from news@localhost) by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id BAA22987 for cardiors-list@hgmp.mrc.ac.uk; Tue, 4 Dec 2001 01:50:42 GMT X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to using -f From: MakeMoneyOnline@isp.com X-Newsgroups: bionet.biology.cardiovascular Subject: Six-figure income from home, guaranteed! Date: 4 Dec 2001 01:50:40 -0000 Organization: BIOSCI/MRC Human Genome Mapping Project Resource Centre Lines: 13 Message-ID: <200112040054.TAA05168@jfius.com> X-Complaints-To: news@net.bio.net X-Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 01CD417AA5 for ; Tue, 4 Dec 2001 01:50:37 +0000 (GMT) X-Received: from jfius.com (server68.aitcom.net [208.234.0.26]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 71B7917A6D for ; Tue, 4 Dec 2001 01:50:36 +0000 (GMT) X-Received: (from sarasota@localhost) by jfius.com (8.8.8/8.8.5) id TAA05168; Mon, 3 Dec 2001 19:54:40 -0500 X-To: Consumer@isp.com To: cardiors@hgmp.mrc.ac.uk Sender: owner-cardiors@hgmp.mrc.ac.uk Precedence: bulk Below is the result of your feedback form. It was submitted by (MakeMoneyOnline@isp.com) on Monday, December 3, 2001 at 19:54:39 --------------------------------------------------------------------------- Recipient: Are you looking to make money online? If you're either looking for a job, tired of your existing job, eager for more pay, or just anxious to have the added freedom and independence that comes with working at home, this email could change your life. We can teach you (in under a half-hour) how to pull in a six-figure income from home... GUARANTEED, or your money back. Click below for more info http://www.instantempires.net/money2/ --------------------------------------------------------------------------- --- From owner-cardiors@hgmp.mrc.ac.uk Wed Dec 5 06:12:34 2001 Return-Path: Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 83E6D17B50 for ; Wed, 5 Dec 2001 06:12:32 +0000 (GMT) Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 9DA5017B4E for ; Wed, 5 Dec 2001 06:12:28 +0000 (GMT) Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 2232117A7E for ; Wed, 5 Dec 2001 06:12:27 +0000 (GMT) Received: (from news@localhost) by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id GAA24985 for cardiors-list@hgmp.mrc.ac.uk; Wed, 5 Dec 2001 06:08:57 GMT X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to using -f From: inetentre9948@Flashmail.com X-Newsgroups: bionet.biology.cardiovascular Subject: Breast Enhancement Cream 100% PROVEN !! Date: 5 Dec 2001 06:08:55 -0000 Organization: BIOSCI/MRC Human Genome Mapping Project Resource Centre Lines: 37 Message-ID: <0000111b7fe3$00006af5$000028d4@mail.Flashmail.com> Mime-Version: 1.0 Content-Type: text/html; charset="iso-8859-1" Content-Transfer-Encoding: quoted-printable X-Complaints-To: news@net.bio.net X-Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id B8E8417AA9 for ; Wed, 5 Dec 2001 06:08:53 +0000 (GMT) X-Received: from fep03-svc.swip.net (fep03.swip.net [130.244.199.131]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 5665617A7E for ; Wed, 5 Dec 2001 06:08:51 +0000 (GMT) X-Received: from intranet.sikroma.se ([193.15.92.168]) by fep03-svc.swip.net with ESMTP id <20011205060849.AII17995.fep03-svc.swip.net@intranet.sikroma.se>; Wed, 5 Dec 2001 07:08:49 +0100 X-Received: from mail.Flashmail.com (26-pool1.ras10.floca.tii-dial.net [209.14.208.26]) by intranet.sikroma.se with SMTP (Microsoft Exchange Internet Mail Service Version 5.5.2653.13) id PJ1WY6DK; Wed, 5 Dec 2001 07:03:40 +0100 X-To: To: cardiors@hgmp.mrc.ac.uk Sender: owner-cardiors@hgmp.mrc.ac.uk Precedence: bulk

  **Breast Enhancement Cream**

 100% PROVEN= and GUARANTEED!!

 Wom= en increased their bust size by over 2"

Give yourself that extra look and
self confidence you deserve!!

 

Visit our site at:

 www.treat yourself.com

 

 

 

 

to be removed= from this e-mal list reply here:
dorisjanus@excite.com

--- From owner-cardiors@hgmp.mrc.ac.uk Wed Dec 5 20:12:35 2001 Return-Path: Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id D214917B6C for ; Wed, 5 Dec 2001 20:12:33 +0000 (GMT) Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 7691217B6F for ; Wed, 5 Dec 2001 20:12:29 +0000 (GMT) Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 04B2217B6A for ; Wed, 5 Dec 2001 20:12:27 +0000 (GMT) Received: (from news@localhost) by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id UAA10179 for cardiors-list@hgmp.mrc.ac.uk; Wed, 5 Dec 2001 20:01:43 GMT X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to using -f From: TOP-LISTING3x@YAHOO.com X-Newsgroups: bionet.biology.cardiovascular Subject: SEARCH ENGINE TRAFFIC NOW Date: 5 Dec 2001 20:01:42 -0000 Organization: BIOSCI/MRC Human Genome Mapping Project Resource Centre Lines: 399 Message-ID: Mime-Version: 1.0 Content-Type: multipart/mixed; boundary="----=_NextPart_000_0064_00000348.00003609" X-Complaints-To: news@net.bio.net X-Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 2FF7517B6A for ; Wed, 5 Dec 2001 20:01:40 +0000 (GMT) X-Received: from blount.mail.mindspring.net (blount.mail.mindspring.net [207.69.200.226]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id AC9A417B5F for ; Wed, 5 Dec 2001 20:01:31 +0000 (GMT) X-Received: from sdn-ar-013azphoep104.dialsprint.net ([63.180.2.64] helo=ghfd) by blount.mail.mindspring.net with smtp (Exim 3.33 #1) id 16BXvU-0000Mv-00; Wed, 05 Dec 2001 04:01:18 -0500 X-To: X-Priority: 3 X-MSMail-Priority: Normal To: cardiors@hgmp.mrc.ac.uk Sender: owner-cardiors@hgmp.mrc.ac.uk Precedence: bulk ------=_NextPart_000_0064_00000348.00003609 Content-Type: text/html;
WE DELIVER TARGETED UNIQUE SEARCH ENGINE
TRAFFIC TO YOUR WEB SITE

BOTTOM LINE
IF YOUR POTENTIAL CUSTOMERS
CAN'T find YOUR WEB SITE in the first 10
to 20 matches ON A SEARCH ENGINE,
YOU JUST LOST MONEY!

IT'S THAT SIMPLE!

Improving search engine TRAFFIC means:
MORE HITS

MORE BUSINESS

MORE SUCCESS
The most important advertising dollar
spent should be for targeted search
engine TRAFFIC!
1. Approximately 95% of all Internet
users start with a search engine query.


 2. Anyone who comes to your site from a
major search engine is 100 times more
likely to become a customer because
they were specifically looking for your
product, goods or services.

 3. Search engine traffic gives you
substantially more for your advertising
dollar than banners or anything else.
Moreover, having a Banner Ad on a
web site doesn't mean your Ad was
seen or even targeted to your market.


 Can't Get Your Companies Web Site
Indexed by the Search Engines?


Unfortunately, this is all too common of
a Problem. You're not the only one
frustrated about the length of time it
takes to be listed, or all the pitfalls involved.
It takes anywhere from 2 days to as much
as 3 months to be listed on all the search engines.

WHEN DO YOU SUBMIT?

Engines at any time delay their indexing
for maintenance and many other reasons.


We Know exactly how each search engine
works, and we know when to submit and what to
submit. Search engines are changing daily and
we study them each day. Your competitors
ARE @ the mercy of OUR Marketing Departments.
Over 6 Years in the search engine wars
and We have Masters words like:
MP3 - BOOKS - WEB SITE HOSTING - MARKETING -
- FREE WEB SITES - CASINO - - CASINO REVIEWS -
BALLS - LOGOS - ART - ATTORNEY'S - NEW CAR PARTS -
OLD CAR PART - - NETWORK MARKETING - WATER FILTERS -
- SCALES - AND THE LIST GOES ON - -

If you've submitted your site and come
to find no listing,

what do you do now?
Contact:

THE CYBER TRAFFIC TECHNICIANS.


You need US in your corner, WE will
take CONTROL of the submission cycle of your
domain.

The cost is 348 US Dollars for 12 months
of service.

This Price is good for this month only
and with this order we give you a free
Consultation to improve
your listings(a $375.00 value). We only
offer this to our clients when they order
the 12 month search engine submission
service. The free Consultation is to make
the necessary changes to improve your
listing and move you to the top of each
Search Engine.

DON'T delay act NOW, Today!!!
People are looking for your company
right now!!!

WE WILL PUT YOUR WEB SITE IN FRONT OF
THEM!!
More Search Engines = More Traffic!

We increase your site's exposure and get
your domain more traffic!

WE submit your domain to 69 (sixty-nine) of
the top search engines!

 It's simple - WE get you indexed on more
search engines and Drive more traffic
to your domain!

We compiled a list of the major
international and domestic search engines!

 This is your opportunity to increase
your domain's traffic, Quickly!
WE update (submit) your domain weekly or
as needed plus, WE provide you with a monthly
report (by request only!)

Here's the complete list:
 AltaVista
HotBot
InfoSeek/Go Network (Web Results)
InfoSeek/Go Network (Proven Picks)
AOL Search
Direct Hit
Excite
Fast/All The Web
Google
Goto.com
IWon
Lycos
MSN
NBCi (Formerly Snap)
Netscape
Open Directory
WebCrawler
Yahoo
Plus
Acoon (Germany)
Aeiwi (USA)
AltaVista (France)
AltaVista (Germany)
AltaVista (Itlay)
AltaVista (Switzerland)
Blitz (Germany)
Excite (Australia)
Excite (France)
Excite (Italy)
Excite (UK)
FindOnce (UK)
Free (France)
FrequentFinders (USA)
GoEureka (Australia)
Indibil (Spain)
InfoMak (USA)
Infoseek (Germany)
InfoTiger (USA)
Lokace (France)
Lycos (Chile)
Lycos (Columbia)
Lycos (France)
Lycos (German)
Lycos (Italian)
Lycos (Japan)
Lycos (Peru)
Lycos (Spain)
Lycos (Sweden)
Lycos (UK)
MaxiSearch (Germany)
Origo (Norway)
QuestFinder (USA)
SearchEngine (UK)
Sharelook (Italy)
ShinySeek (Italy)
Speedfind (Germany)
SplatSearch (USA)
Spray (France)
SunSteam (Norway)
SuperSnooper (USA)
Superva (Italian)
Sympatico (Canadian)
UK Max (UK)
Unearth (New Zealand)
Voila (France)
Voila (Spain)
Walhello (USA)
WebSearch (Australia)
WebWombat (Australia)
Yagua (Paraguay)
It's easy to get started!!

Just fax or mail the following to:

 FAX: 1- (602) 392-8288.

US MAIL:
 CyberCo
8190 W Deer Valley Road Suite 104-265
Peoria, AZ 85382
WE WILL CONTACT YOU IN 2 BUSINESS DAYS
AND WE DO NOT START THE WORK UNTIL
WE SPEAK WITH YOU!!


-- Order Form --

PAYMENT TYPES:

CHECK - CREDIT CARD - MONEY ORDER

All orders must be completely filled
out!

Company Name:

Address:

State: City:
Zip:

Contact Name:

Contact Telephonel:

Contact Fax:

Contact E-mail Address:

Web site Address:


A few of your top Keywords:

Questions:

Credit Card #.

Name On Card.

Sign Here:__________________________________

Date:_____________

 --*** NOTE ***--
348.00 US Dollars WILL COVER 12 MONTHS
OF SERVICE.






















--------------------------------------
--------------------------------------
To be removed from future mailings!!!!
All REMOVE requests AUTOMATICALLY
honored upon receipt.
href="mailto:sendhere09@excite.com?subject=NOBIZ"mail
to:
sendhere09@excite.com?subject=NOBIZ
PLEASE understand that any effort to disrupt, close or block
this REMOVE account can only result in difficulties for others
wanting to be removed from our mailing list as it will be impossible
to take anyone off the list if the remove instruction is not received.


----------------------------------------
----------------------------------




 --- From owner-cardiors@hgmp.mrc.ac.uk Thu Dec 6 01:42:33 2001 Return-Path: Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 0BA1E17A99 for ; Thu, 6 Dec 2001 01:42:33 +0000 (GMT) Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 5503817AAA for ; Thu, 6 Dec 2001 01:42:29 +0000 (GMT) Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id B7E4617A99 for ; Thu, 6 Dec 2001 01:42:27 +0000 (GMT) Received: (from news@localhost) by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id BAA23642 for cardiors-list@hgmp.mrc.ac.uk; Thu, 6 Dec 2001 01:40:50 GMT X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to using -f From: "guolin" X-Newsgroups: bionet.biology.cardiovascular Subject: dfd Date: Thu, 6 Dec 2001 09:59:48 +0800 Organization: Changzhou Telecom Lines: 3 Message-ID: <9umi98$12an$1@news.cz.js.cn> X-Complaints-To: usenet@news.cn99.com X-Priority: 3 X-MSMail-Priority: Normal X-Newsreader: Microsoft Outlook Express 5.00.2615.200 X-MimeOLE: Produced By Microsoft MimeOLE V5.00.2615.200 To: cardiors@hgmp.mrc.ac.uk Sender: owner-cardiors@hgmp.mrc.ac.uk Precedence: bulk dfghfhfghdfhedfh From owner-cardiors@hgmp.mrc.ac.uk Thu Dec 6 02:12:34 2001 Return-Path: Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 93F1917A9F for ; Thu, 6 Dec 2001 02:12:33 +0000 (GMT) Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id B955417AB3 for ; Thu, 6 Dec 2001 02:12:29 +0000 (GMT) Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 0983117A99 for ; Thu, 6 Dec 2001 02:12:27 +0000 (GMT) Received: (from news@localhost) by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id CAA23817 for cardiors-list@hgmp.mrc.ac.uk; Thu, 6 Dec 2001 02:10:41 GMT X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to using -f From: "guo" X-Newsgroups: bionet.biology.cardiovascular Subject: er Date: Thu, 6 Dec 2001 10:24:55 +0800 Organization: Changzhou Telecom Lines: 3 Message-ID: <9umk16$19ld$1@news.cz.js.cn> X-Complaints-To: usenet@news.cn99.com X-Priority: 3 X-MSMail-Priority: Normal X-Newsreader: Microsoft Outlook Express 5.00.2615.200 X-MimeOLE: Produced By Microsoft MimeOLE V5.00.2615.200 To: cardiors@hgmp.mrc.ac.uk Sender: owner-cardiors@hgmp.mrc.ac.uk Precedence: bulk gasdfgfadsgfdgfd From owner-cardiors@hgmp.mrc.ac.uk Thu Dec 6 14:57:34 2001 Return-Path: Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id A7FBD17AB2 for ; Thu, 6 Dec 2001 14:57:33 +0000 (GMT) Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id F124317ACC for ; Thu, 6 Dec 2001 14:57:29 +0000 (GMT) Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id ADADC17AC7 for ; Thu, 6 Dec 2001 14:57:28 +0000 (GMT) Received: (from news@localhost) by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id OAA04417 for cardiors-list@hgmp.mrc.ac.uk; Thu, 6 Dec 2001 14:51:19 GMT X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to using -f From: Jim Watrous X-Newsgroups: bionet.biology.cardiovascular Subject: Simulation request Date: Thu, 06 Dec 2001 09:51:15 -0500 Organization: Biology Dept - SJU Message-ID: <3C0F85E3.1FEA8529@sju.edu> X-Mailer: Mozilla 4.72 [en] (Win98; U) X-Accept-Language: en,pdf MIME-Version: 1.0 Content-Type: text/plain; charset=us-ascii Content-Transfer-Encoding: 7bit X-Complaints-To: newsabuse@supernews.com Lines: 8 To: cardiors@hgmp.mrc.ac.uk Sender: owner-cardiors@hgmp.mrc.ac.uk Precedence: bulk I am looking for text file versions of systems like the Ruo-Rudy model of ventricular action potentials, or similar models based on atrial cells, etc. I teach a biological modeling course and would like to include this material in my course next semester. thanks Jim Watrous From owner-cardiors@hgmp.mrc.ac.uk Sat Dec 8 07:57:41 2001 Return-Path: Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id C63B917A5F for ; Sat, 8 Dec 2001 07:57:39 +0000 (GMT) Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id CA08417B48 for ; Sat, 8 Dec 2001 07:57:35 +0000 (GMT) Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 7226B17A5F for ; Sat, 8 Dec 2001 07:57:33 +0000 (GMT) Received: (from news@localhost) by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id HAA26907 for cardiors-list@hgmp.mrc.ac.uk; Sat, 8 Dec 2001 07:51:40 GMT X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to using -f From: flowerlucy98@excite.com ("Donny Boroughs") X-Newsgroups: bionet.biology.cardiovascular Subject: Alternates #62F8 Date: 8 Dec 2001 07:51:38 -0000 Organization: BIOSCI/MRC Human Genome Mapping Project Resource Centre Lines: 374 Message-ID: <200112080740.fB87eTF26618@mail.cibi.net.ph> Mime-Version: 1.0 Content-Type: multipart/mixed; boundary="----=_NextPart_000_007F_01BDF6C7.FABAC1B0" Content-Transfer-Encoding: 7bit X-Complaints-To: news@net.bio.net X-Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id DD37117A5E for ; Sat, 8 Dec 2001 07:51:36 +0000 (GMT) X-Received: from mail.cibi.net.ph (unknown [203.167.85.149]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 1A24C17A5F for ; Sat, 8 Dec 2001 07:51:28 +0000 (GMT) X-Received: from host (localhost.localdomain [127.0.0.1]) by mail.cibi.net.ph (8.10.1/8.10.1) with ESMTP id fB87eTF26618; Sat, 8 Dec 2001 15:40:29 +0800 X-To: forms349@mail.cibi.net.ph X-Mailer: Microsoft Outlook Express 4.72.1712.3 X-MimeOLE: Produced By Microsoft MimeOLE V羞D.1712.3 To: cardiors@hgmp.mrc.ac.uk Sender: owner-cardiors@hgmp.mrc.ac.uk Precedence: bulk This is a MIME Message ------=_NextPart_000_007F_01BDF6C7.FABAC1B0 Content-Type: multipart/alternative; boundary="----=_NextPart_001_0080_01BDF6C7.FABAC1B0" ------=_NextPart_001_0080_01BDF6C7.FABAC1B0 Content-Type: text/plain; charset="iso-8859-1" Content-Transfer-Encoding: quoted-printable ***** This is an HTML Message ! ***** ------=_NextPart_001_0080_01BDF6C7.FABAC1B0 Content-Type: text/html; charset="iso-8859-1" Content-Transfer-Encoding: quoted-printable FREE Computer With Merchant Account Setup

COMPLETE CREDIT CARD PROCESSING SYSTEMS FOR YOUR BUSINESS=2E INTERNE= T - HOME BASED - MAIL ORDER - PHONE ORDER

Do you accept credit cards? Your competition does!

 

Everyone Approved - Credit Problems OK!
Approval in less than 24 hours!
Increase your sales by 300%
Start Accepting Credit Cards on your website!
Free Information, No Risk, 100% confidential=2E
Your name and information will not be sold to thrid parties!
Home Businesses OK! Phone/Mail Order OK!
No Application Fee, No Setup Fee!
Close More Impulse Sales!

Everyone Approved!

Good Credit or Bad!  To= apply today, please fill out the express form below=2E It contains all the information we need to get your account approved=2E For a= rea's that do not apply to you please put "n/a" in the box=2E

Upon receipt, we'll fax you with all of the all Bank Card Application documents necessary to establish your Merchant Account=2E Once returned we= can have your account approved within 24 hours=2E
 

Service Industry Standard

US
Site Inspection $50 - $75 FREE
Shipping $50 - $75 FREE
Warranty $10 Per Month= FREE
Sales Receipts $10 - $50&nbs= p; FREE
Fraud Screening

$=2E50 - $1=2E00
Per Transaction

 FREE
Amex Set Up $50 - $75 FREE
24 Hour Help Line $10 Month FREE
Security Bond $5000- $10,00= 0
Or More		 NONE

This is a No Obligation Qualification Form and is your first step to accepting credit cards=2E By filling out this form you will= "not enter" in to any obligations o= r contracts with us=2E We will use it to determine the best p= rogram to offer you based on the information you provide=2E You will be c= ontacted by one of our representatives within 1-2 business days to go over = the rest of your account set up=2E

<= font color=3D"#cc0000">Note:  All Information Provided To Us Will Remain= 100% Confidential !! 

Apply Free With No Risk!

Pleas= e fill out the express application form completely=2E
Incomplete information m= ay prevent us from properly processing your application=2E
Your Full Emai= l Address:
be sure to use your full address (i= =2Ee=2E user@domain=2Ecom)
Your Name:
Business Name:=
Business Phone= Number:
Home Phone Num= ber:
Type of Busine= ss:
Retail Business
Mail Order Business
Internet Based Busines= s
Personal Credi= t Rating:
Excellent
Good
Fair
Poor
How Soon Would= You Like a Merchant Account?


Your info= rmation is confidential, it will not be sold or used for any other purpose,= and you are under no obligation=2E Your information will be used solely for the purpose of evaluating= your business or website for a merchant account so that you may begin acce= pting credit card payments=2E


List Removal/OPT-OUT Option
Click Herem ------=_NextPart_001_0080_01BDF6C7.FABAC1B0-- ------=_NextPart_000_007F_01BDF6C7.FABAC1B0-- --- From owner-cardiors@hgmp.mrc.ac.uk Sun Dec 9 21:27:41 2001 Return-Path: Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id AAB8017A74 for ; Sun, 9 Dec 2001 21:27:40 +0000 (GMT) Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 1DAD817AC8 for ; Sun, 9 Dec 2001 21:27:37 +0000 (GMT) Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id B169C17AC7 for ; Sun, 9 Dec 2001 21:27:35 +0000 (GMT) Received: (from news@localhost) by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id VAA12490 for cardiors-list@hgmp.mrc.ac.uk; Sun, 9 Dec 2001 21:14:25 GMT X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to using -f From: krzyszto@hotmail.com (Krzysztof Wroblewski) X-Newsgroups: bionet.biology.cardiovascular Subject: Fetal Echocardiography Date: Mon, 10 Dec 2001 00:16:00 GMT Organization: none Lines: 17 Message-ID: <3c13feab.16357189@netnews.upenn.edu> Reply-To: krzyszto@hotmail.com X-Newsreader: Forte Free Agent 1.1/32.230 To: cardiors@hgmp.mrc.ac.uk Sender: owner-cardiors@hgmp.mrc.ac.uk Precedence: bulk Fetal Echocardiography Homepage located at http://www.med.upenn.edu/fetus provides the largest publicly accessible library of high quality fetal heart images obtained using different ultrasound techniques: 2D-echo, Color Doppler, M-mode, and Pulse Doppler. The Homepage contains also fetal calculator to determine gestational age using typical ultrasound measurements, and a Discussion Forum to provide means for exchange of information about fetal echocardiography, cardiology, and general fetal ultrasound. Access to Free Medline, Meriam-Webster Dictionary and several electronic journals, as well as hundreds of links to all aspects of cardiology, telemedicine, and imaging (including visual male and female) makes this page a perfect place not only for physicians, medical students, and medical professionals but for everybody interested in fetal development, and all aspects of medicine. From owner-cardiors@hgmp.mrc.ac.uk Mon Dec 10 18:12:55 2001 Return-Path: Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 30E3717AE8 for ; Mon, 10 Dec 2001 18:12:54 +0000 (GMT) Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 54E7717AF1 for ; Mon, 10 Dec 2001 18:12:42 +0000 (GMT) Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id CE02C17AF4 for ; Mon, 10 Dec 2001 18:12:37 +0000 (GMT) Received: (from news@localhost) by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id SAA09841 for cardiors-list@hgmp.mrc.ac.uk; Mon, 10 Dec 2001 18:04:11 GMT X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to using -f From: monpost6562@freemail.hu X-Newsgroups: bionet.biology.cardiovascular Subject: Big savings using online home loans! Date: 10 Dec 2001 18:04:09 -0000 Organization: BIOSCI/MRC Human Genome Mapping Project Resource Centre Lines: 56 Message-ID: <20011210180401.F102417AFB@mercury.hgmp.mrc.ac.uk> Mime-Version: 1.0 Content-Type: text/html; charset="iso-8859-1" Content-Transfer-Encoding: quoted-printable X-Complaints-To: news@net.bio.net X-Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 90ECB17AE1 for ; Mon, 10 Dec 2001 18:04:05 +0000 (GMT) X-Received: from ly.gov.tw (mail.ly.gov.tw [210.69.138.20]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id F102417AFB for ; Mon, 10 Dec 2001 18:04:00 +0000 (GMT) X-Received: from cpqml530 [10.11.1.111] by ly.gov.tw [192.168.1.1] with SMTP (MDaemon.v3.0.0.R) for ; Tue, 11 Dec 2001 02:02:53 +0800 X-Received: from 65.139.106.30 by cpqml530 (InterScan E-Mail VirusWall NT); Tue, 11 Dec 2001 02:04:04 +0800 X-To: X-Priority: 3 X-MSMail-Priority: Normal X-MDaemon-Deliver-To: cardiors@net.bio.net X-Return-Path: monpost6562@freemail.hu X-MDRcpt-To: staden-users@net.bio.net X-MDRemoteIP: 10.11.1.111 To: cardiors@hgmp.mrc.ac.uk Sender: owner-cardiors@hgmp.mrc.ac.uk Precedence: bulk

Interest Rates Have Never Been More Attractive!

Now is the time to refinance your home, consolidate all of y= our high interest 
credit card debt, and possibly receive up to 125% of your home's value.&nb= sp;
 Get all of the cash you'll need!

All= USA Homeowners Easily Qualify!

Damage= d Credit Is never a problem!

 We work with hundreds of nation-wide lenders who are hungry 
for your business and will provide you with the b= est deal on the INTERNET!

Our service is 100% free!

CLICK HERE For = a No Obligation Quotation Today!

We = strongly oppose the use of SPAM email and do not want anyone who does not wish to r= eceive 
our  mailings to receive them. Please click here to be deleted from further communication
CLICK HERE = TO BE EXCLUDED

--- From owner-cardiors@hgmp.mrc.ac.uk Wed Dec 12 01:57:45 2001 Return-Path: Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 9F81817A8A for ; Wed, 12 Dec 2001 01:57:44 +0000 (GMT) Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 8800A17A8E for ; Wed, 12 Dec 2001 01:57:41 +0000 (GMT) Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 0BA0617A8A for ; Wed, 12 Dec 2001 01:57:39 +0000 (GMT) Received: (from news@localhost) by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id BAA26018 for cardiors-list@hgmp.mrc.ac.uk; Wed, 12 Dec 2001 01:50:55 GMT X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to using -f From: pina@astaga.com X-Newsgroups: bionet.biology.cardiovascular Subject: Amazing Daily Pics Date: 12 Dec 2001 01:50:51 -0000 Organization: BIOSCI/MRC Human Genome Mapping Project Resource Centre Lines: 332 Message-ID: <0000434e35ba$00003eca$0000297d@pop3.sina.com.cn> Mime-Version: 1.0 Content-Type: text/html; charset="iso-8859-1" Content-Transfer-Encoding: quoted-printable X-Complaints-To: news@net.bio.net X-Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 19DA617A64 for ; Wed, 12 Dec 2001 01:50:48 +0000 (GMT) X-Received: from finch-post-10.mail.demon.net (finch-post-10.mail.demon.net [194.217.242.38]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id A503117A8A for ; Wed, 12 Dec 2001 01:50:35 +0000 (GMT) X-Received: from mailgate.account-alliance.co.uk ([62.49.232.234] helo=chandler.account-alliance.co.uk) by finch-post-10.mail.demon.net with esmtp (Exim 2.12 #1) id 16DyVW-0007jo-0A; Wed, 12 Dec 2001 01:48:26 +0000 X-Received: from pop3.sina.com.cn (ip186.toronto76.dialup.canada.psi.net [154.20.70.186]) by chandler.account-alliance.co.uk with SMTP (Microsoft Exchange Internet Mail Service Version 5.5.2448.0) id XA38FQQH; Wed, 12 Dec 2001 01:50:15 -0000 X-To: X-Reply-To: testera4@hotmail.com To: cardiors@hgmp.mrc.ac.uk Sender: owner-cardiors@hgmp.mrc.ac.uk Precedence: bulk Free Sex Daily


Today's Free Pics
babe   hardcore   cheerleader=    teen hardcore<= /a>   fetish<= /a> oldergals   tit fucking = hardcore   erotic h= ardcore sex   dirty old mole= s  unfaithful   bizarre&nbs= p;  teen babe&n= bsp; 

The world's largest, nastiest, filthiest latin website
Thousands of high quality interracial pictures! The Worlds Biggest Blacks Stretching White Pussies To The Maxi= mum, Watch Them Scream With Pleasure. Complete archive of the infamous "dogfart" pictures. Over 19,000 and cou= nting. New exclusive "dogfart" content updated weekly  Click Here for Free Interracial Hardcore!

VOTED #1 NASTIEST SITE ON = THE NET
1000's of Anal Penetration and Oral Se= x Pictures, Double Penetration, Huge Cocks, Vegatables, Anal Dildos, Facial Cumshots, Live Sex Shows, Bukkake, And Much More
Click Here for Award Winning Site - Free!

VOTED 2001 TEEN SITE OF TH= E YEAR
High Quality Images Of Beautiful Young= Teens . Watch Teen Babes Take Cocks In Every Hole. Free Live Chat With Our Teen Babes 24 Hours A Day - Your Wish Is Their Command!!<= /font>
Click Here For Free Membership!

EXPLICIT, UNCENSORED SLUT WIFES!<= /font>
When it comes to being satisf= ied, their wedding vows don't mean shit! 1001 stories of slut wives cheating = on their men -- with other men and sometimes other women! Watch Real Sluts Shower, Masturbate, And Get The Fucking They Dese= rve! Slut Stories, Personals, Nasty Chat, Interracial, Pregnant, Mature Sluts, Cheating Wives And Much More
CLICK HERE FOR FREE ADMISSION!

FREE TEEN SEX= SHOWS!
 More than just pics here! The nets largest collection of= LIVE TEN SEX SHOWS! Banned In The U.S.A! You Will Not Believe Your Eyes!
FREE SEX -- CLICK HERE!

Note: this is = not a spam email. This email was sent to you because your email was entered in on= a website
requesting to be a registered subscriber. If you would would like to b= e removed from our list,
CLICK HERE TO CANCEL YOUR ACCOUNT and you will *never* receive an= other email from us!

--- From owner-cardiors@hgmp.mrc.ac.uk Wed Dec 12 09:12:49 2001 Return-Path: Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id B2B7117AAA for ; Wed, 12 Dec 2001 09:12:48 +0000 (GMT) Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 6FE1C17B55 for ; Wed, 12 Dec 2001 09:12:43 +0000 (GMT) Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 2C79517B53 for ; Wed, 12 Dec 2001 09:12:41 +0000 (GMT) Received: (from news@localhost) by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id JAA00348 for cardiors-list@hgmp.mrc.ac.uk; Wed, 12 Dec 2001 09:12:29 GMT X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to using -f From: "sarula" X-Newsgroups: bionet.biology.cardiovascular Subject: 你好 Date: Wed, 12 Dec 2001 15:56:34 +0800 Organization: Changzhou Telecom Lines: 3 Message-ID: <9v771p$4ar$2@news.cz.js.cn> X-Complaints-To: usenet@news.cn99.com X-Priority: 3 X-MSMail-Priority: Normal X-Newsreader: Microsoft Outlook Express 5.00.2314.1300 X-MimeOLE: Produced By Microsoft MimeOLE V5.00.2314.1300 To: cardiors@hgmp.mrc.ac.uk Sender: owner-cardiors@hgmp.mrc.ac.uk Precedence: bulk 我是一生中专生，我想交朋友，世界上的少男少女，我的QQ号：33077400 From owner-cardiors@hgmp.mrc.ac.uk Thu Dec 13 03:27:47 2001 Return-Path: Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 9228E17B65 for ; Thu, 13 Dec 2001 03:27:46 +0000 (GMT) Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 8ADDA17B68 for ; Thu, 13 Dec 2001 03:27:43 +0000 (GMT) Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 2C4F417B65 for ; Thu, 13 Dec 2001 03:27:42 +0000 (GMT) Received: (from news@localhost) by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id DAA27246 for cardiors-list@hgmp.mrc.ac.uk; Thu, 13 Dec 2001 03:27:35 GMT X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to using -f From: Ma Hongbao X-Newsgroups: bionet.biology.cardiovascular Subject: Re: Living is a right Date: Wed, 12 Dec 2001 22:25:32 -0500 Organization: Michigan State University Lines: 7 Message-ID: <3C181FAC.8060408@netscape.net> References: <3C0BF2C9.90402@netscape.net> Mime-Version: 1.0 Content-Type: text/plain; charset=us-ascii; format=flowed Content-Transfer-Encoding: 7bit User-Agent: Mozilla/5.0 (Windows; U; Win 9x 4.90; en-US; rv:0.9.4) Gecko/20011019 Netscape6/6.2 X-Accept-Language: en-us To: cardiors@hgmp.mrc.ac.uk Sender: owner-cardiors@hgmp.mrc.ac.uk Precedence: bulk test Ma Hongbao wrote: > All humans have the same right to live in the world. > From owner-cardiors@hgmp.mrc.ac.uk Thu Dec 13 23:42:53 2001 Return-Path: Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 6B13E17AEF for ; Thu, 13 Dec 2001 23:42:51 +0000 (GMT) Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 46D2517AF0 for ; Thu, 13 Dec 2001 23:42:47 +0000 (GMT) Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 781E717AEF for ; Thu, 13 Dec 2001 23:42:45 +0000 (GMT) Received: (from news@localhost) by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id XAA26645 for cardiors-list@hgmp.mrc.ac.uk; Thu, 13 Dec 2001 23:31:25 GMT X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to using -f From: "Ashley Glover" X-Newsgroups: bionet.biology.cardiovascular Subject: Over 200 Pharmaceutical Reports Now Available Online Date: Thu, 13 Dec 2001 22:57:46 -0000 X-Priority: 3 X-MSMail-Priority: Normal X-Newsreader: Microsoft Outlook Express 5.00.2314.1300 X-MimeOLE: Produced By Microsoft MimeOLE V5.00.2314.1300 Lines: 766 Message-ID: <3c193a41$0$8507$cc9e4d1f@news.dial.pipex.com> X-Complaints-To: abuse@uk.uu.net To: cardiors@hgmp.mrc.ac.uk Sender: owner-cardiors@hgmp.mrc.ac.uk Precedence: bulk Over 200 Pharmaceutical Reports Now Available Online Reports cover individual companies, specific markets, therapeutic areas, new technologies, new regulations, drug pricing, reimbursement, wholesale, distribution, generics, genetics, drug deliver, medical devices, and much more... Available now on www.pharma-i.com are the following pharma, biotech and related life sciences reports Each report has a full executive summary and comprehensive index to view online at www.pharma-i.com For more information visit www.pharma-i.com or email aglover@smi-online.co.uk or call SMi Customer Services +44 (0) 207 827 6000 Reports Listing : Cancer: Drug delivery systems Drug delivery systems are a growing sector of the pharmaceutical industry. The backbone of the sector is hinged on research and development into new ways of delivering therapeutic agents for the treat... The R&D Intelligence Report Series The R&D Intelligence Report Series consists of nine separate electronic reports, each providing a complete breakdown of R&D activity within a specific therapeutic area. R&D Intelligence report series (Viral Infections) R&D Intelligence Report: Viral Infections, provides a current illustration of the antiviral market, broken down by number of drugs in development and therapeutic indication. R&D Intelligence report series (Respiratory) R&D Intelligence Report: Respiratory, provides a current illustration of the respiratory market, broken down by number of drugs in development and therapeutic indication. R&D Intelligence report series (Inflammatory Disorders) R&D Intelligence Report: Inflammatory Disorders, provides a current illustration of the anti-inflammatory market, broken down by number of drugs in development and therapeutic indication. R&D Intelligence report series (Immune Disorders) R&D Intelligence Report: Immune Disorders, provides an overview of the immune drugs market, broken down by number of compounds in development and therapeutic indication. R&D Intelligence report series (Endocrine) R&D Intelligence Report: Endocrine, provides you with an insight into the current state of the endocrine market, which is broken down by number of drugs in development and therapeutic indication. R&D Intelligence report series (CNS Disorders) R&D Intelligence Report: CNS, provides you with an insight into the current state of the CNS market, which is broken down by number of drugs in development and therapeutic indication. R&D Intelligence report series (Cardiovascular Disease) R&D Intelligence Report: Cardiovascular Disease, provides you with an insight into the current state of the cardiovascular market, which is broken down by number of drugs in development and therapeuti... R&D Intelligence report series (Cancer) R&D Intelligence Report: Cancer, provides you with an insight into the current state of the cancer market, broken down by number of drugs in development and therapeutic indication. R&D Intelligence report series (Bacterial Infections) R&D Intelligence Report: Bacterial Infections, provides you with an insight into the current state of the antibacterial market, which is broken down by number of drugs in development and therapeutic i... HIV and AIDS - Developments and Therapeutics The focus of the report is the pharmacology behind HIV and Aids. Social and political aspects form the backdrop. But anyone involved with Aids who needs the facts will benefit from this valuable resou... eHealth Tools and eHealth Management: Opportunities and challenges for pharma companies and MCOs The Internet has the potential to radically alter healthcare costs, drug delivery and development - In order for these positive changes to happen, Internet applications and tools are needed that facil... Pharmaceutical Companies Analysis - Yamanouchi A Comprehensive and independent analysis of Yamanouchi Pharmaceutical Companies Analysis - Warner-Lambert A Comprehensive and independent analysis of Warner-Lambert Pharmaceutical Companies Analysis - UCB A Comprehensive and independent analysis of UCB Pharmaceutical Companies Analysis - Tanabe Seiyaku A Comprehensive and independent analysis of Tanabe Seiyaku Pharmaceutical Companies Analysis - Takeda A Comprehensive and independent analysis of Takeda Pharmaceutical Companies Analysis - Sumitomo Chemical A Comprehensive and independent analysis of Sumitomo Chemical Pharmaceutical Companies Analysis - Solvay A Comprehensive and independent analysis of Solvay Pharmaceutical Companies Analysis - Smithkline Beecham A Comprehensive and independent analysis of Smithkline Beecham Pharmaceutical Companies Analysis - Shionogi A Comprehensive and independent analysis of Shionogi Pharmaceutical Companies Analysis - Serono A Comprehensive and independent analysis of Serono Pharmaceutical Companies Analysis - Schering-Plough A Comprehensive and independent analysis of Schering-Plough Pharmaceutical Companies Analysis - Schering AG A Comprehensive and independent analysis of Schering AG Pharmaceutical Companies Analysis - Sanofi-Synthelabo A Comprehensive and independent analysis of Sanofi-Synthelabo Pharmaceutical Companies Analysis - Sankyo A Comprehensive and independent analysis of Sankyo Pharmaceutical Companies Analysis - Roche A Comprehensive and independent analysis of Roche Pharmaceutical Companies Analysis - Rh鬾e-Poulenc A Comprehensive and independent analysis of Rh鬾e-Poulenc Pharmaceutical Companies Analysis - Recordati A Comprehensive and independent analysis of Recordati Pharmaceutical Companies Analysis - Procter & Gamble A Comprehensive and independent analysis of Procter & Gamble Pharmaceutical Companies Analysis - Pharmacia & Upjohn A Comprehensive and independent analysis of Pharmacia Upjohn Pharmaceutical Companies Analysis - Pfizer A Comprehensive and independent analysis of Pfizer Pharmaceutical Companies Analysis - Otsuka A Comprehensive and independent analysis of Otsuka Pharmaceutical Companies Analysis - Novo Nordisk A Comprehensive and independent analysis of Novo Nordisk Pharmaceutical Companies Analysis - Novartis A Comprehensive and independent analysis of Novartis Pharmaceutical Companies Analysis - Monsanto A Comprehensive and independent analysis of Monsanto Pharmaceutical Companies Analysis - Merck & Co A Comprehensive and independent analysis of Merck & Co Pharmaceutical Companies Analysis - Merck KGaA A Comprehensive and independent analysis of Merck KGaA Pharmaceutical Companies Analysis - Lundbeck A Comprehensive and independent analysis of Lundbeck Pharmaceutical Companies Analysis - Kyowa Hakko A Comprehensive and independent analysis of Kyowa Hakko Pharmaceutical Companies Analysis - Johnson & Johnson A Comprehensive and independent analysis of Johnson & Johnson Pharmaceutical Companies Analysis - Hoechst A Comprehensive and independent analysis of Hoechst Pharmaceutical Companies Analysis - Glaxo Wellcome A Comprehensive and independent analysis of Glaxo Wellcome Pharmaceutical Companies Analysis - Fujisawa A Comprehensive and independent analysis of Fujisawa Pharmaceutical Companies Analysis - Eli Lilly A Comprehensive and independent analysis of Eli Lilly Pharmaceutical Companies Analysis - Eisai A Comprehensive and independent analysis of Eisai Pharmaceutical Companies Analysis - DuPont Pharmaceuticals A Comprehensive and independent analysis of DuPont Pharmaceuticals Pharmaceutical Companies Analysis - Dainippon A Comprehensive and independent analysis of Dainippon Pharmaceutical Companies Analysis - Daiichi A Comprehensive and independent analysis of Daiichi Pharmaceutical Companies Analysis - Chugai A Comprehensive and independent analysis of Chugai Pharmaceutical Companies Analysis - Bristol Myers Squibb A Comprehensive and independent analysis of Bristol Myers Squibb Pharmaceutical Companies Analysis - Boehringer Ingelheim A Comprehensive and independent analysis of Boehringer Ingelheim Pharmaceutical Companies Analysis - Bayer A Comprehensive and independent analysis of Bayer Pharmaceutical Companies Analysis - BASF A Comprehensive and independent analysis of BASF Pharmaceutical Companies Analysis - Astrazeneca A Comprehensive and independent analysis of Astrazeneca Pharmaceutical Companies Analysis - Asta Medica A Comprehensive and independent analysis of Asta Medica Pharmaceutical Companies Analysis - Amgen A Comprehensive and independent analysis of Amgen Pharmaceutical Companies Analysis - American Home Products A Comprehensive and independent analysis of American Home Products Pharmaceutical Companies Analysis - Altana (Byk Gulden) A Comprehensive and independent analysis of Altana Pharmaceutical Companies Analysis - Allergan A Comprehensive and independent analysis of Allergan Pharmaceutical Companies Analysis - Akzo Nobel A Comprehensive and independent analysis of Akzo Nobel Pharmaceutical Companies Analysis - Abbott Laboratories A Comprehensive and independent analysis of Abbott Laboratories Pharmaceutical Companies Analysis - Companies Pharmaceutical Companies Analysis Comprehensive and independent analysis of major pharmaceutical companies worldwide. World Pharmaceutical Markets - Vietnam A complete review of the Vietnamese pharmaceutical market World Pharmaceutical Markets - United States A complete review of the US pharmaceutical market World Pharmaceutical Markets - United Kingdom A complete review of the UK pharmaceutical market World Pharmaceutical Markets - Ukraine A complete review of the Ukraine pharmaceutical market World Pharmaceutical Markets - Turkey A complete review of the Turkish pharmaceutical market World Pharmaceutical Markets - Thailand A complete review of the Thai pharmaceutical market World Pharmaceutical Markets - Taiwan A complete review of the Taiwan pharmaceutical market World Pharmaceutical Markets - Switzerland A complete review of the Swiss pharmaceutical market World Pharmaceutical Markets - Sweden A complete review of the Swedish pharmaceutical market World Pharmaceutical Markets - Spain A complete review of the Spanish pharmaceutical marke World Pharmaceutical Markets - South Africa A complete review of the South African pharmaceutical market World Pharmaceutical Markets - Slovenia A complete review of the Slovenian pharmaceutical market World Pharmaceutical Markets - Slovakia A complete review of the Slovakian pharmaceutical market World Pharmaceutical Markets - Singapore A complete review of the Singapore pharmaceutical market World Pharmaceutical Markets - Saudi Arabia A complete review of the Saudi Arabia pharmaceutical market World Pharmaceutical Markets - Russia A complete review of the Russian pharmaceutical market World Pharmaceutical Markets - Romania A complete review of the Romanian pharmaceutical market World Pharmaceutical Markets - Portugal A complete review of the Portuguese pharmaceutical market World Pharmaceutical Markets - Poland A complete review of the Polish pharmaceutical market World Pharmaceutical Markets - Philippines A complete review of the Philippines pharmaceutical market World Pharmaceutical Markets - Peru A complete review of the Peruvian pharmaceutical market World Pharmaceutical Markets - Pakistan A complete review of the Pakistan pharmaceutical market World Pharmaceutical Markets - Norway A complete review of the Norweigan pharmaceutical market World Pharmaceutical Markets - New Zealand A complete review of the New Zealand pharmaceutical market World Pharmaceutical Markets - Netherlands A complete review of the Dutch pharmaceutical market World Pharmaceutical Markets - Morocco A complete review of the Moroccan pharmaceutical market World Pharmaceutical Markets - Mexico A complete review of the Mexican pharmaceutical market World Pharmaceutical Markets - Malaysia A complete review of the Malaysian pharmaceutical market World Pharmaceutical Markets - Lithuania A complete review of the Lithuanian pharmaceutical market World Pharmaceutical Markets - Latvia A complete review of the Latvian pharmaceutical market World Pharmaceutical Markets - Korea A complete review of the Korean pharmaceutical market World Pharmaceutical Markets - Japan A complete review of the Japanese pharmaceutical market World Pharmaceutical Markets - Italy A complete review of the Italian pharmaceutical market World Pharmaceutical Markets - Israel A complete review of the Israeli pharmaceutical market World Pharmaceutical Markets - Ireland A complete review of the Irish pharmaceutical market World Pharmaceutical Markets - Indonesia A complete review of the Indonesian pharmaceutical market World Pharmaceutical Markets - India A complete review of the Indian pharmaceutical market World Pharmaceutical Markets - Hungary A complete review of the Hungarian pharmaceutical market World Pharmaceutical Markets - Hong Kong A complete review of the Hong Kong pharmaceutical market World Pharmaceutical Markets - Greece A complete review of the Greek pharmaceutical market World Pharmaceutical Markets - Germany A complete review of the German pharmaceutical market World Pharmaceutical Markets - France A complete review of the French pharmaceutical market World Pharmaceutical Markets - Finland A complete review of the Finnish pharmaceutical market World Pharmaceutical Markets - Estonia A complete review of the Estonian pharmaceutical market World Pharmaceutical Markets - Egypt A complete review of the Egyptian pharmaceutical market World Pharmaceutical Markets - Denmark A complete review of the Danish pharmaceutical market World Pharmaceutical Markets - Czech Republic A complete review of the Czech pharmaceutical market World Pharmaceutical Markets - Cuba A complete review of the Cuban pharmaceutical market World Pharmaceutical Markets - Croatia A complete review of the Croatian pharmaceutical market World Pharmaceutical Markets - China A complete review of the Chinese pharmaceutical market World Pharmaceutical Markets - Colombia A complete review of the Colombian pharmaceutical market World Pharmaceutical Markets - Chile A complete review of the Chilean pharmaceutical market World Pharmaceutical Markets - Canada A complete review of the Canadian pharmaceutical market World Pharmaceutical Markets - Brazil A complete review of the Brazilian pharmaceutical market World Pharmaceutical Markets - Belgium A complete review of the Belgian pharmaceutical market World Pharmaceutical Markets - Bangladesh A complete review of the Bangladesh pharmaceutical market World Pharmaceutical Markets - Austria A complete review of the Austrian pharmaceutical market World Pharmaceutical Markets - Australia A complete review of the Australian pharmaceutical market World Pharmaceutical Markets - Argentina A complete review of the Argentinean pharmaceutical market World Pharmaceutical Markets A complete review of key pharmaceutical markets around the globe NEW - The Blockbuster Drugs Outlook: Optimum management strategies throughout the product lifecycle This report identifies current and potential areas for blockbuster development, matching R&D activities against unmet need. Foodborne Microorganisms and Natural Toxins The Center for Food Safety and Applied Nutrition (CFSAN) has prepared a handbook on foodborne pathogenic microorganisms (bacteria, viruses and parasites) and natural toxins. Each chapter focuses mainl... Future Pain Drugs 'Very comprehensive coverage of all the current thinking concerning pain mechanisms ,suggests future directions and recently identified targets for pain research ,an invaluable reference for anyone in... The Fourth Hurdle; Pharmacoeconomics in Europe SMi Publishing's new management report is designed for health economists, regulatory, legal and marketing directors and managers. You will be taken through the many different pharmacoeconomic and cost... Superbugs and Superdrugs: Innovation in Anti-Infectives Superbugs and Superdrugs: A Strategic Guide to the Global Antimicrobials Industry, Innovation and Therapies provides extensive and logical analysis of the global antimicrobials industry, giving an in... The UK Pharmaceutical Market Development Report MBD's UK Pharmaceutical products market development report includes both basic pharmaceutical products and pharmaceutical preparations sectors. The basic pharmaceutical products sector consists of th... Pharmaceutical Pricing Strategies As healthcare cost-containment intensifies and pricing freedom is eroded, the need to develop new strategies to maintain and justify the premium pricing of drugs becomes increasingly urgent. Generic Pharmaceuticals Outlook, 1998-2008 Currently estimated to account for approximately 11% of global pharmaceutical sales, this figure looks set to rise dramatically as branded drugs come off-patent within the next decade. Cancer Market Outlook 1998-2010 The cancer market, though small, is growing rapidly and was valued at nearly $13m in 1997. The Future for Self-Medication in Poland Poland is probably the most attractive transition market emerging from the old central and eastern European block. US Healthcare Market into the 21st Century The US PoM market was worth $73bn in 1997 and is forecast to double in size in the next seven years. The development of new strategies to meet changing regulatory requirements, patient and provider ex... Regulatory Affairs: Paths to Approval The steady overall increase in the time taken for a drug to gain marketing authorisation has led to increased pressure on regulatory authorities to modify and improve the drug approval process. Pharmaceutical Profitability Outlook Escalating competition, healthcare reforms and the rising cost of R&D are increasingly threatening the traditionally high profitability of pharmaceutical manufacturers. Pharmaceutical Outsourcing Outlook The streamlining of pharmaceutical companies that has taken place in recent years has allowed them to focus resources and investment on core specialities. Pharmaceutical OTC Market to 2005 This report focuses on the development of the OTC market in terms of the current dynamics and future evolution. Pharmaceutical M&A: The Third Wave Consolidation in the pharmaceutical industry has occurred in two historical waves of activity. The third wave has just begun with a number of different high profile mergers. Pharmaceutical Industry in the 21st Century: Strategies for Success Does the 21st century herald the beginning of a genomics revolution? Which disease areas will provide the greatest growth potential and why? Pharmaceutical Distribution Outlook How will the US, European and Japanese distribution markets change over the next 10 years? Patient Power: The Shift Towards More Powerful, More Informed Consumers of Drugs The dramatic rise in patient power in recent years presents a new and challenging opportunity to pharmaceutical companies, healthcare providers and governments alike. Managed Care in Global Healthcare Markets Resulting from a desire to rid the economy of skyrocketing health inflation, the cost-controlling methods of managed care, pioneered by America's earliest HMO's, are providing the inspiration for cost... Lifestyle Drugs Outlook to 2005 The lure of easy-to-swallow pills that promise to cure impotence, obesity, hair loss, wrinkles, and even sadness, has captured the public imagination. However, these panaceas for modern living raise q... Integrating Genomics: The Next Generation Although its possibilities have not yet been fully realised, experts view genomics as pivotal to improving innovation in the drug discovery process. Healthcare Informatics into the 21st Century The pressure to contain costs and increase efficiency within the healthcare sector has led to increased horizontal and vertical integration as well as the development of new healthcare concepts such a... Global Pharmaceuticals: A Market, Company and Disease Analysis What are the key challenges facing pharmaceutical manufacturers? Who are the market leaders in each sector? What strategies are they pursuing and will these prove successful? Global Orthopaedic Markets: Bridging the Divide In recent years, the worldwide orthopaedic industry has changed from what some considered a stagnant or mature market into a dynamic and rapidly changing medical sector. The Evolution of DTC Marketing across key pharmaceutical markets For many years, the pharmaceutical industry believed that it was being denied access to the most influential sector of the healthcare industry: the patient sector. ePharmacies: Strategic Implications for the Healthcare Industry Within the healthcare sector, on-line pharmacies have recently attracted unprecedented levels of media interest. Although still in its infancy, the US e-pharmacy industry is forecast to generate onlin... Top Ten and Emerging Pharmaceutical Markets The global pharmaceutical market, valued at $280bn in 1998, is growing rapidly. eHealth Content: Healthcare Information on the Internet Global Internet user population is forecast to be 413 million by the year 2003, a 157% increase on the user population of 161 million in 1998. eHealth Connectivity: Linking Payers, Providers & Patients It is important to provide clear segmentation of the rapidly evolving healthcare Internet industry. Current Internet based initiatives can be segmented into three distinct areas: content, connectivity... Drug Delivery Outlook to 2005 Within today's more restrictive market conditions, pharmaceutical companies are being forced to develop increasingly competitive strategies to enable them to prosper. Diagnostics Outlook to 2005 Healthcare cost-containment and a largely fragmented market have driven the need for diagnostic companies to consolidate in order to maintain their market position. Bridging the Pharmaceutical Earnings Gap: Key Strategies in the race for growth Based on a comprehensive survey of industry opinion and trends, this incisive management report identifies the major threats to future industry growth and investigates how these work in combination to... Antisense Therapy: Technical Aspects and Commercial Opportunities A review of the spectrum of antisense technologies reveals that considerable progress has been made during the past decade. The Generics Outlook 2001 The cyclical generics industry is once again on the upswing, following a period of destructive price wars -driven by consolidation amongst drug distributors- real growth in the sector is outpacing gro... Update: Pharmaceutical Pricing Strategies 2000: Entering the New Millennium The favorable climate of the pharmaceutical sector has changed radically over the past ten years; where once a company's freedom over pricing decisions was almost limitless, external pressures such as... The Pharmacogenomics Outlook Pharmaceutical companies are coming under increasing pressure to increase the quality of their products, and optimize and accelerate drug discovery and development. Update: The Cancer Outlook 2000 Driven by the cytotoxic, adjunct and innovative drug classes, the cancer market grew by 16% in 1999 to a global value of almost $19bn, and is now poised on the verge of a period of significant expansi... Update: The Cardiovascular Outlook 2000 In 1999, cardiovascular drugs represented the largest single segment of the global pharmaceutical industry by value, with estimated sales of $69.6bn represented growth of 8.2% over 1998 levels. Pain Therapeutics: A Strategic Re-evaluation Pain management, though not a life-threatening disease, will have its proper place in the future healthcare system because the disability and economic loss in addition to personal suffering caused by ... The Drug Discovery Outlook: Drivers of innovation in the 21st Century The Drug Discovery Outlook: Drivers of innovation in the 21st Century introduces and analyzes the five key enabling technologies and bioinformatics, which are currently driving pharmaceutical drug dis... Update: The CNS Outlook 2000 The Central Nervous System (CNS) market has shown sustained growth in 1999 with the expansion continuing to be driven by several factors; A greater understanding of the neuropharmacological mechanisms... European Self-medication Country Market Series 12 Countries - 10 Reports Self-medication in Europe to 2003 - 5 New Reports A series of five examining the self-medication market Pathways to Success - Setting the new standard in Rx to OTC Switching In this strategic report, James Dudley examines the process of switching from prescription only or semi-ethical status to OTC. Winning Strategies - Successful innovation beyond Rx to OTC Switching Winning strategies - written by Europe's leading consumer healthcare marketing strategist In Search of Growth - New Solutions for the Future Probably the most important and extensive study of the European non-prescription market ever produced.......... The Future for Non-Prescription Pharmaceuticals in France - 2004 An exposure of the real opportunities, threats and challenges in a rapidly reforming market. U.S. Microarray/DNA-CHIP industry; Current Status and Future Outlook, 2000-2010 This report presents U.S. Microarray / biochip industry's current and future trends. OTC Distribution in Europe, Exploring the Processes of Change - 2005 An in-depth strategic analysis and data base for one of the major change drivers in European health-care marketing. Skin Care in Self-Medication - Europe The only real in-depth strategic analysis of this greatly under exploited consumer health-care opportunity Vitamins, Minerals, Herbal Suppliments and Tonics in Self-Medication in Europe This is the largest and most up-to-date strategic analysis of the dietary supplements and tonics market in Europe with 630 pages 557 graphs, tables & figures Biometrics Report CNS Drugs and CNS Markets CNS disorders have been practically ignored by the industry in the past, but they are all diseases that are on the increase, partly due to the ageing population. There is an unmet demand for new thera... European Pharmaceutical Wholesaling and Distribution "an informative and practical review of the latest developments in the wholesaling and distribution of pharmaceutical products in Europe" European Regulatory Environment for Medical Devices "Mastery of the complex EU guidelines is the only way to successfully compete with increasingly intense European and American competition" New Approaches In Cancer Therapeutics Scientific advances and novel technologies in biomedical disciplines such as genetic engineering, genomics, proteomics, immunology, chemistry and cell biology have led to new tools for developing inno... Pricing & Reimbursement In the European Pharmaceutical Industry Recent trends and developments in the pricing and reimbursement of pharmaceuticals in the EC are having a fundamental and significant impact on the marketing strategy, and the subsequent structural or... The UK Health Datamine - Practical Access to NHS Knowledge How often have you spent time looking for information about the NHS, when you urgently needed to know what is happening and why? Now for all those selling into the NHS who need a cost-effective pract... What's in the Pipeline on CD-Rom An interactive, searchable database of more than 8,200 pharmaceutical compounds in development from pre-clinical through awaiting approval. What's in the Pipeline presents products from more than 600 ... Pharma Business A business magazine edited specifically for the international pharmaceutical community. Pharma business covers news, issues, events, clinical research, and marketing activities affecting pharmaceutica... Orthopaedics Business More than ever before, the orthopaedic sector is taking a central position in industry research efforts. Orthopaedics Business incorporates a wide range of primary source material, augmented with data... Medical Industry Week Medical Industry Week (MIW) is a weekly newsletter (46 issues per annum) providing the latest information on companies and their products. Anti-Infectives Drug News Anti-Infectives Drug News (AIN) offers global coverage of the anti-infectives market and makes tracking of drug & company developments easy. Pharmaceutical Company Insight Pharmaceutical Company Insight (PCI) focuses on the activities of pharmaceutical companies worldwide and provides a unique competitive perspective. Pharma Agreement News Pharmaceutical companies have always collaborated on drug research, development, production and marketing. However, against a background of corporate restructuring the number of collaborations has ris... Cardiovascular Drug News For the pharmaceutical industry, research interest has never been higher as the hunt for blockbuster products that offer truly improved economic outcomes and real patient benefits is contested by near... CNS Drug News Industry interest in the conditions of the central nervous system is at an all time high, and with an aging population, those illnesses affecting the elderly are increasingly driving clinical developm... Cancer Drug News Cancer Drug News (CDN) can save you the time and effort of ensuring you have the necessary information to keep up-to-date with the developments in this world market. Cardiovascular Device Business While cardiovascular conditions remain one of the biggest killers in developed societies, medical device industry interest will remain high. The hunt for products that offer truly improved clinical an... Pharmaceutical Automation Updates - Software Management Basics Pharmaceutical Automation guide written by experts for all to understand Pharmaceutical Automation Updates - Producing a Quality Plan Pharmaceutical Automation guide written by an expert for all to understand More Details... Each report has a full executive summary and comprehensive index to view online at www.pharma-i.com For more information visit www.pharma-i.com or email aglover@smi-online.co.uk or call SMi Customer Services +44 (0) 207 827 6000 From owner-cardiors@hgmp.mrc.ac.uk Fri Dec 14 16:57:52 2001 Return-Path: Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 3B64C17A8F for ; Fri, 14 Dec 2001 16:57:51 +0000 (GMT) Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id DC9D717B17 for ; Fri, 14 Dec 2001 16:57:48 +0000 (GMT) Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id AE4B817AFF for ; Fri, 14 Dec 2001 16:57:47 +0000 (GMT) Received: (from news@localhost) by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id QAA13703 for cardiors-list@hgmp.mrc.ac.uk; Fri, 14 Dec 2001 16:52:35 GMT X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to using -f From: 1PLACEMENTservicex@hotmail.com X-Newsgroups: bionet.biology.cardiovascular Subject: RE:SUPERCHARGE WEB TRAFFIC!!!! Date: 14 Dec 2001 16:52:34 -0000 Organization: BIOSCI/MRC Human Genome Mapping Project Resource Centre Lines: 399 Message-ID: Mime-Version: 1.0 Content-Type: multipart/mixed; boundary="----=_NextPart_000_2AAB_0000385D.000029D9" X-Complaints-To: news@net.bio.net X-Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id E89A617B2E for ; Fri, 14 Dec 2001 16:52:31 +0000 (GMT) X-Received: from mclean.mail.mindspring.net (mclean.mail.mindspring.net [207.69.200.57]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 8F7CF17AFF for ; Fri, 14 Dec 2001 16:52:30 +0000 (GMT) X-Received: from sdn-ar-011azphoep103.dialsprint.net ([63.178.187.63] helo=ette) by mclean.mail.mindspring.net with smtp (Exim 3.33 #1) id 16EbHv-000766-00; Thu, 13 Dec 2001 14:13:03 -0500 X-To: X-Priority: 3 X-MSMail-Priority: Normal To: cardiors@hgmp.mrc.ac.uk Sender: owner-cardiors@hgmp.mrc.ac.uk Precedence: bulk ------=_NextPart_000_2AAB_0000385D.000029D9 Content-Type: text/html;
WE DELIVER TARGETED UNIQUE SEARCH ENGINE
TRAFFIC TO YOUR WEB SITE

BOTTOM LINE
IF YOUR POTENTIAL CUSTOMERS
CAN'T find YOUR WEB SITE in the first 10
to 20 matches ON A SEARCH ENGINE, YOU
JUST LOST MONEY!
IT'S THAT SIMPLE!

Improving search engine TRAFFIC means:
MORE HITS

MORE BUSINESS

MORE SUCCESS
The most important advertising dollar
spent should be for search engine
TRAFFIC!
1. Approximately 95% of all Internet
users start with a search engine query.


 2. Anyone who comes to your site from a
major search
engine is 100 times more likely to
become a customer
because they were specifically looking
for your product,
goods or services.

 3. Search engine traffic gives you
substantially more
for your advertising dollar than banners
or anything else.
Moreover, having a Banner Ad on a web
site doesn't mean your Ad
was seen or even targeted to your
market.


 Can't Get Your Companies Web Site
Indexed by the Search Engines?


Unfortunately, this is all too common of
a Problem. You're not the only one
frustrated about the length of time it
takes to be listed, or all the pitfalls involved.
It takes anywhere from 2 days to as much
as 3 months to be listed on all the search engines.

WHEN DO YOU SUBMIT?

Engines at any time delay their indexing
for maintenance and many other reasons.


WE Know exactly how each search engine
works, and we know when to submit and what to
submit. Search engines are changing daily and
we study them each day. Your competitors
ARE @ the mercy of OUR Marketing Departments.
Over 6 Years in the search engine wars
and We have Masters words like:
MP3 - BOOKS - WEB SITE HOSTING - MARKETING -
- FREE WEB SITES - CASINO - - CASINO REVIEWS -
BALLS - LOGOS - ART - ATTORNEY'S - NEW CAR PARTS -
OLD CAR PART - - NETWORK MARKETING - WATER FILTERS -
- SCALES - AND THE LIST GOES ON - -

If you've submitted your site and come
to find no listing,

what do you do now?
Contact:

THE CYBER TRAFFIC TECHNICIANS.


You need US in your corner, WE will
take CONTROL of the submission cycle of your
domain.

The cost is 348 US Dollars for 12 months
of service.

This Price is good for this month only
and with this order we give you a free
Consultation after 100 days to improve
your listings(a $375.00 value). We only
offer this to our clients when they order
the 12 month search engine submission
service. The free Consultation is to make
the necessary changes to improve your
listing and move you to the top of each
Search Engine.

When you start our service we do not
make any changes to your web site and
after 100 days we only make suggestions
that WILL improve your search engine placement.


DON'T delay act NOW, Today!!!

People are looking for your company
right now!!!


WE WILL PUT YOUR WEB SITE IN FRONT OF
THEM!!
More Search Engines = More Traffic!

WE increase your site's exposure and get
your domain more traffic!

WE submit your domain to 69 (sixty-nine)
search engines!

 It's simple - WE get you indexed on more
search engines and
Drive more traffic to your domain!

We compiled a list of the major
international and domestic search engines!

This is your opportunity to increase
your domain's traffic,
Quickly!

WE update (submit) your domain weekly or
as needed plus, WE provide you with a monthly
report (by request only!)

Here's the complete list:
 AltaVista
HotBot
InfoSeek/Go Network (Web Results)
InfoSeek/Go Network (Proven Picks)
AOL Search
Direct Hit
Excite
Fast/All The Web
Google
Goto.com
IWon
Lycos
MSN
NBCi (Formerly Snap)
Netscape
Open Directory
WebCrawler
Yahoo
Plus
Acoon (Germany)
Aeiwi (USA)
AltaVista (France)
AltaVista (Germany)
AltaVista (Itlay)
AltaVista (Switzerland)
Blitz (Germany)
Excite (Australia)
Excite (France)
Excite (Italy)
Excite (UK)
FindOnce (UK)
Free (France)
FrequentFinders (USA)
GoEureka (Australia)
Indibil (Spain)
InfoMak (USA)
Infoseek (Germany)
InfoTiger (USA)
Lokace (France)
Lycos (Chile)
Lycos (Columbia)
Lycos (France)
Lycos (German)
Lycos (Italian)
Lycos (Japan)
Lycos (Peru)
Lycos (Spain)
Lycos (Sweden)
Lycos (UK)
MaxiSearch (Germany)
Origo (Norway)
QuestFinder (USA)
SearchEngine (UK)
Sharelook (Italy)
ShinySeek (Italy)
Speedfind (Germany)
SplatSearch (USA)
Spray (France)
SunSteam (Norway)
SuperSnooper (USA)
Superva (Italian)
Sympatico (Canadian)
UK Max (UK)
Unearth (New Zealand)
Voila (France)
Voila (Spain)
Walhello (USA)
WebSearch (Australia)
WebWombat (Australia)
Yagua (Paraguay)
It's easy!!
Just fax or mail the following to:
 FAX: 1-(602) 392-8288.

 US MAIL:
 CyberCO
8190 W Deer Valley Road Suite 104-265
Peoria, AZ 85382
WE WILL CONTACT YOU IN 2 BUSINESS DAYS
AND WE DO NOT START THE WORK UNTIL
WE SPEAK WITH YOU!!


-- Order Form --

PAYMENT TYPES:

CHECK - CREDIT CARD - MONEY ORDER

All orders must be completely filled
out!

Company Name:

Address:

State: City:
Zip:

Contact Name:

Contact Telephonel:

Contact Fax:

Contact E-mail Address:

Web site Address:


A few of your top Keywords:

Questions:

Credit Card #.

Name On Card.

Sign Here:__________________________________

Date:_____________

--*** NOTE ***--
348.00 US Dollars WILL COVER 12 MONTHS
OF SERVICE.























--------------------------------------
--------------------------------------
To be removed from future mailings!!!!
All REMOVE requests AUTOMATICALLY
honored upon receipt.
href="mailto:sendhere11@excite.com?subject=NOBIZ"mail
to:
sendhere11@excite.com?subject=NOBIZ
PLEASE understand that any effort to disrupt, close or block
this REMOVE account can only result in difficulties for others
wanting to be removed from our mailing list as it will be impossible
to take anyone off the list if the remove instruction is not received.


----------------------------------------
----------------------------------




 --- From owner-cardiors@hgmp.mrc.ac.uk Sat Dec 15 11:27:55 2001 Return-Path: Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 1A18017A9F for ; Sat, 15 Dec 2001 11:27:54 +0000 (GMT) Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 681A417A8E for ; Sat, 15 Dec 2001 11:27:51 +0000 (GMT) Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 1C85C17A88 for ; Sat, 15 Dec 2001 11:27:50 +0000 (GMT) Received: (from news@localhost) by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id LAA07267 for cardiors-list@hgmp.mrc.ac.uk; Sat, 15 Dec 2001 11:25:44 GMT X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to using -f From: 1PLACEMENT6x@YAHOO.com X-Newsgroups: bionet.biology.cardiovascular Subject: RE:SEARCH ENGINE TRAFFIC NOW Date: 15 Dec 2001 11:25:43 -0000 Organization: BIOSCI/MRC Human Genome Mapping Project Resource Centre Lines: 399 Message-ID: Mime-Version: 1.0 Content-Type: multipart/mixed; boundary="----=_NextPart_000_696C_000070D6.00006C66" X-Complaints-To: news@net.bio.net X-Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 7A03017A8E for ; Sat, 15 Dec 2001 11:25:41 +0000 (GMT) X-Received: from blount.mail.mindspring.net (blount.mail.mindspring.net [207.69.200.226]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id DC47217A56 for ; Sat, 15 Dec 2001 11:25:39 +0000 (GMT) X-Received: from sdn-ar-001azphoep050.dialsprint.net ([206.133.138.34] helo=lapq) by blount.mail.mindspring.net with smtp (Exim 3.33 #1) id 16Eqet-0007T9-00; Fri, 14 Dec 2001 06:37:45 -0500 X-To: X-Priority: 1 X-MSMail-Priority: High To: cardiors@hgmp.mrc.ac.uk Sender: owner-cardiors@hgmp.mrc.ac.uk Precedence: bulk ------=_NextPart_000_696C_000070D6.00006C66 Content-Type: text/html;
WE DELIVER TARGETED UNIQUE SEARCH ENGINE
TRAFFIC TO YOUR WEB SITE

BOTTOM LINE
IF YOUR POTENTIAL CUSTOMERS
CAN'T find YOUR WEB SITE in the first 10
to 20 matches ON A SEARCH ENGINE, YOU
JUST LOST MONEY!
IT'S THAT SIMPLE!

Improving search engine TRAFFIC means:
MORE HITS

MORE BUSINESS

MORE SUCCESS
The most important advertising dollar
spent should be for search engine
TRAFFIC!
1. Approximately 95% of all Internet
users start with a search engine query.


 2. Anyone who comes to your site from a
major search
engine is 100 times more likely to
become a customer
because they were specifically looking
for your product,
goods or services.

 3. Search engine traffic gives you
substantially more
for your advertising dollar than banners
or anything else.
Moreover, having a Banner Ad on a web
site doesn't mean your Ad
was seen or even targeted to your
market.


 Can't Get Your Companies Web Site
Indexed by the Search Engines?


Unfortunately, this is all too common of
a Problem. You're not the only one
frustrated about the length of time it
takes to be listed, or all the pitfalls involved.
It takes anywhere from 2 days to as much
as 3 months to be listed on all the search engines.

WHEN DO YOU SUBMIT?

Engines at any time delay their indexing
for maintenance and many other reasons.


WE Know exactly how each search engine
works, and we know when to submit and what to
submit. Search engines are changing daily and
we study them each day. Your competitors
ARE @ the mercy of OUR Marketing Departments.
Over 6 Years in the search engine wars
and We have Masters words like:
MP3 - BOOKS - WEB SITE HOSTING - MARKETING -
- FREE WEB SITES - CASINO - - CASINO REVIEWS -
BALLS - LOGOS - ART - ATTORNEY'S - NEW CAR PARTS -
OLD CAR PART - - NETWORK MARKETING - WATER FILTERS -
- SCALES - AND THE LIST GOES ON - -

If you've submitted your site and come
to find no listing,

what do you do now?
Contact:

THE CYBER TRAFFIC TECHNICIANS.


You need US in your corner, WE will
take CONTROL of the submission cycle of your
domain.

The cost is 348 US Dollars for 12 months
of service.

This Price is good for this month only
and with this order we give you a free
Consultation after 100 days to improve
your listings(a $375.00 value). We only
offer this to our clients when they order
the 12 month search engine submission
service. The free Consultation is to make
the necessary changes to improve your
listing and move you to the top of each
Search Engine.

When you start our service we do not
make any changes to your web site and
after 100 days we only make suggestions
that WILL improve your search engine placement.


DON'T delay act NOW, Today!!!

People are looking for your company
right now!!!


WE WILL PUT YOUR WEB SITE IN FRONT OF
THEM!!
More Search Engines = More Traffic!

WE increase your site's exposure and get
your domain more traffic!

WE submit your domain to 69 (sixty-nine)
search engines!

 It's simple - WE get you indexed on more
search engines and
Drive more traffic to your domain!

We compiled a list of the major
international and domestic search engines!

This is your opportunity to increase
your domain's traffic,
Quickly!

WE update (submit) your domain weekly or
as needed plus, WE provide you with a monthly
report (by request only!)

Here's the complete list:
 AltaVista
HotBot
InfoSeek/Go Network (Web Results)
InfoSeek/Go Network (Proven Picks)
AOL Search
Direct Hit
Excite
Fast/All The Web
Google
Goto.com
IWon
Lycos
MSN
NBCi (Formerly Snap)
Netscape
Open Directory
WebCrawler
Yahoo
Plus
Acoon (Germany)
Aeiwi (USA)
AltaVista (France)
AltaVista (Germany)
AltaVista (Itlay)
AltaVista (Switzerland)
Blitz (Germany)
Excite (Australia)
Excite (France)
Excite (Italy)
Excite (UK)
FindOnce (UK)
Free (France)
FrequentFinders (USA)
GoEureka (Australia)
Indibil (Spain)
InfoMak (USA)
Infoseek (Germany)
InfoTiger (USA)
Lokace (France)
Lycos (Chile)
Lycos (Columbia)
Lycos (France)
Lycos (German)
Lycos (Italian)
Lycos (Japan)
Lycos (Peru)
Lycos (Spain)
Lycos (Sweden)
Lycos (UK)
MaxiSearch (Germany)
Origo (Norway)
QuestFinder (USA)
SearchEngine (UK)
Sharelook (Italy)
ShinySeek (Italy)
Speedfind (Germany)
SplatSearch (USA)
Spray (France)
SunSteam (Norway)
SuperSnooper (USA)
Superva (Italian)
Sympatico (Canadian)
UK Max (UK)
Unearth (New Zealand)
Voila (France)
Voila (Spain)
Walhello (USA)
WebSearch (Australia)
WebWombat (Australia)
Yagua (Paraguay)
It's easy!!
Just fax or mail the following to:
 FAX: 1-(602) 392-8288.

 US MAIL:
 CyberCO
8190 W Deer Valley Road Suite 104-265
Peoria, AZ 85382
WE WILL CONTACT YOU IN 2 BUSINESS DAYS
AND WE DO NOT START THE WORK UNTIL
WE SPEAK WITH YOU!!


-- Order Form --

PAYMENT TYPES:

CHECK - CREDIT CARD - MONEY ORDER

All orders must be completely filled
out!

Company Name:

Address:

State: City:
Zip:

Contact Name:

Contact Telephonel:

Contact Fax:

Contact E-mail Address:

Web site Address:


A few of your top Keywords:

Questions:

Credit Card #.

Name On Card.

Sign Here:__________________________________

Date:_____________

--*** NOTE ***--
348.00 US Dollars WILL COVER 12 MONTHS
OF SERVICE.























--------------------------------------
--------------------------------------
To be removed from future mailings!!!!
All REMOVE requests AUTOMATICALLY
honored upon receipt.
href="mailto:sendhere11@excite.com?subject=NOBIZ"mail
to:
sendhere11@excite.com?subject=NOBIZ
PLEASE understand that any effort to disrupt, close or block
this REMOVE account can only result in difficulties for others
wanting to be removed from our mailing list as it will be impossible
to take anyone off the list if the remove instruction is not received.


----------------------------------------
----------------------------------




 ---